Dianthus Therapeutics
DNTH
DNTH
74 hedge funds and large institutions have $769M invested in Dianthus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 30
3% less funds holding
Funds holding: 76 → 74 (-2)
Holders
74
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$40.3M | |
| 2 | +$18.3M | |
| 3 | +$11M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$10M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$9.49M |
Top Sellers
| 1 | -$8.32M | |
| 2 | -$6.51M | |
| 3 | -$6.16M | |
| 4 |
Walleye Capital
New York
|
-$5.71M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.6M |